BioPharma

11 June, 2026 | Thursday | News

Formation Bio Doses First Participant in Phase I Trial of Lynk’s CNS-Penetrant TYK2 Inhibitor

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseases, today announced a significant clinical milestone ac...

Lab

11 June, 2026 | Thursday | News

Waters Launches Coin Cell DSC to Advance Battery Safety Testing and Thermal Analysis

Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. Unique whole-cell design eliminates cell teardown, reducing sample...

BioTech

11 June, 2026 | Thursday | News

SK Bioscience Licenses CDC Rotavirus Vaccine Technology to Advance Global Immunisation Efforts

SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention SK bioscience is jointly investing with the RIGHT Foundation to drive process development that e...

Contract Services

10 June, 2026 | Wednesday | News

Chime Biologics Expands Manufacturing Capacity With New GMP-2 Facility And AI Powered Megafactory Vision

Chime Biologics’ manufacturing expansion builds on a decade of collaboration enabled by  Cytiva’s modular manufacturing platform  Designed to support late-phase and commercial manufactu...

Consumer Health

10 June, 2026 | Wednesday | News

AI Must Shift Healthcare From Crisis Response To Early Intervention Across APAC

As healthcare systems across Asia Pacific confront mounting workforce shortages, ageing populations, and rising chronic disease burdens, artificial intelligence is emerging as a critical enabler of more efficie...

Medtech

05 June, 2026 | Friday | News

MEDIPOST Secures FDA Agreement for Single Pivotal Phase 3 Study of CARTISTEM

MEDIPOST, a fully integrated commercial stage cell therapy biotechnology company, announced today that it has secured the FDA's agreement to conduct a single pivotal Phase 3 study for CARTISTEM® in the U.S....

Cell & Gene

03 June, 2026 | Wednesday | Analysis

Curative but Unaffordable: Gene and Cell Therapy's Access Paradox in Asia

At almost every cell-and-gene-therapy conference in the region, the same slide appears: a child who was dying of leukaemia, now in durable remission; a teenager freed from a lifetime of blood transfusions; a gr...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close